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Abstract
Background: There is some evidence that plasma insulin levels might influence
ovarian cancer risk. Glyacemic index (GI) and glycaemic load (GL) are measures that
allow the carbohydrate content of individual foods to be classified according to their
postprandial glycaemic effects and hence their effects on circulating insulin levels.
Therefore, we examined ovarian cancer risk in association with GI and GL, and intake
of dietary carbohydrate and sugar.
Methods: The study was conducted in a prospective cohort of 49 613 Canadian
women enrolled in the National Breast Screening Study (NBSS) who completed a self-
administered food-frequency questionnaire (FFQ) between 1980 and 1985. Linkages
to national mortality and cancer databases yielded data on deaths and cancer
incidence, with follow-up ending between 1998 and 2000. Data from the FFQ were
used to estimate overall GI and GL, and Cox proportional hazards models were used
to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association
between energy-adjusted quartile levels of GL, overall GI, total carbohydrates, total
sugar and ovarian cancer risk.
Results: During a mean 16.4 years of follow-up, we observed 264 incident ovarian
cancer cases. GI and total carbohydrate and sugar intakes were not associated with
ovarian cancer risk in the total cohort. GL was positively associated with a 72%
increase in risk of ovarian cancer (HR ¼ 1.72, 95% CI ¼ 1.13–2.62, Ptrend ¼ 0.01) and
the magnitude of the association was slightly greater among postmenopausal
(HR ¼ 1.89, 95% CI ¼ 0.98–3.65, Ptrend ¼ 0.03) than among premenopausal women
(HR ¼ 1.64, 95% CI ¼ 0.95–2.88, Ptrend ¼ 0.07).
Conclusions: Our data suggest that consumption of diets with high GL values may be







Ovarian cancer is the fourth most frequent cause of cancer
death among women1, with 5-year survival rates averaging
between 25 and 30%2. Increased ovarian synthesis of sex
steroid hormones may contribute to the development of
ovarian cancer3. Insulin has been shown to stimulate
ovarian production of androgens4,5, which are direct
precursors of oestrogen synthesis. Insulin has also been
shown to downregulate synthesis of insulin-like growth
factor-binding protein-1 (IGFBP-1), thereby increasing
unbound levels of insulin-like growth factor-I (IGF-I) and
hence IGF-I activity6–9. IGFs, which are produced in the
ovaries and elsewhere in the body1, have been implicated
in ovarian tumorigenesis10.
The glycaemic index (GI) is a means of classifying the
carbohydrate content of individual foods according to
their postprandial glycaemic effects and hence their effects
on blood insulin levels11–13. Low-GI diets are associated
with a relatively low postprandial rise in insulin14, and
high-GI diets are associated with hyperinsulinae-
mia11,15,16. Glycaemic load (GL) is a measure of the total
glycaemic effect of the diet. It can be estimated using both
GI values and the carbohydrate content of foods15, and
therefore it reflects both the type and the amount of
dietary carbohydrate consumed. Given the effects of high-
GI and high-GL diets on circulating insulin levels, it is
conceivable that such diets might be associated with an
increased risk of ovarian cancer via modulation of ovarian
oestrogen synthesis3.
To date, it appears that the relationship between overall
GI and GL and ovarian cancer risk has been examined in
only one epidemiological study17. In that investigation, a
case–control study in Italy, the authors found statistically
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significant positive associations between GI, GL, total
carbohydrate intake and ovarian cancer risk17. Given the
current lack of data regarding these relationships, we
examined the relationship between overall GI and GL, as
well as total carbohydrate and total sugar consumption
(included because of their strong association with
postprandial insulin response18,19), and ovarian cancer
risk in a prospective cohort study of Canadian women.
Materials and methods
Study population
The design of the study has been described in detail
elsewhere20. Briefly, 89 835 women aged 40–59 years
were recruited into the Canadian National Breast Screen-
ing Study (NBSS) between 1980 and 1985 from the general
Canadian population by various means, including
personal invitation by letter, group mailings to employees
of large institutions and to members of professional
associations, advertisements in newspapers, and public
service announcements on radio and television21. Women
enrolled in the NBSS were randomised to either the
screening arm or the control arm, and were followed-up to
assess rates of referral for screening, rates of detection of
breast cancer from screening and from community care,
nodal status, tumour size and rates of death from all causes
and from breast cancer22.
Questionnaires
At recruitment into the cohort, participants completed self-
administered questionnaires that sought information on
demographic characteristics, lifestyle factors, menstrual
and reproductive history, and use of oral contraceptives
and replacement oestrogens. Women who reported
having regular menstrual periods within the past 12
months were classified as premenopausal. Women whose
menstrual periods ceased at least 12 months before
enrolment into the study were considered to be
post-menopausal23.
Starting in 1982 (i.e. after some participants had
completed their scheduled visits to the screening centres),
a self-administered food-frequency questionnaire (FFQ)
was distributed to all new attendees at all screening
centres and to women returning to the screening centres
for re-screening24. The FFQ sought information on usual
portion size and frequency of consumption of 86 food
items, and included photographs of various portion sizes
to assist respondents with quantifying intake. A compari-
son between the self-administered questionnaire and a full
interviewer-administered questionnaire, which has been
subjected to both validity and reliability testing24 and used
in a number of epidemiological studies25, revealed that the
two methods gave estimates of intake of the major
macronutrients and dietary fibre which strongly correlated
with each other (correlation coefficients ranged from 0.47
for cholesterol to 0.72 for vegetable protein; for dietary
fibre, the correlation coefficient was 0.70)24. A total of
49 613 dietary questionnaires were returned and available
for analysis.
Calculation of nutrient intake, overall glycaemic
index and glycaemic load
Data from the completed self-administered FFQs were
used to estimate daily intake of nutrients using a database
for Canadian foods that has been described elsewhere25.
Data from the FFQ were also used to estimate overall GI
and GL. GI values of foods were obtained from published
reports based on studies in North America15. Total dietary
GL was calculated by multiplying the carbohydrate
content (in grams) of a standard serving size of a given
food item by the number of servings of that food item
consumed per day and by its GI value, and then summing
the values for all food items reported. Overall GI, a
variable that represents the relative proportion of high-GI
foods in the diet26, was calculated by dividing the total
dietary GL by the total carbohydrate content of the diet.
When the reported GI values for foods were observed to
vary across studies, we used the mean of the reported
values of GI for that food. The main foods contributing to
GL in the cohort are listed in a footnote to Table 1.
Ascertainment of incident ovarian cancer cases and
deaths
Incident ovarian cancer cases and deaths amongst cohort
members were ascertained, respectively, by means of
computerised record linkages to the Canadian Cancer
Database and to the National Mortality Database, both of
which are maintained by Statistics Canada. The linkages to
the databases yielded data on cancer incidence and
mortality to 31 December 2000 for women in Ontario, 31
December 1998 for women in Quebec, and 31 December
1999 for women in other provinces.
Statistical analysis
Of the 49 613 women for whom dietary data were
available, we excluded women with extreme energy
intake values (at least three standard deviations above or
below the mean value for loge caloric intake) (n ¼ 502);
women with prevalent ovarian cancer at baseline
(n ¼ 20); and women who had undergone a bilateral
oophorectomy prior to enrolment in the study (n ¼ 315).
These exclusions left 48 776 women available for analysis,
amongst whom there were 264 incident cases of ovarian
cancer. Study participants were considered to be at risk
from their date of enrolment until the date of diagnosis of
ovarian cancer, the date of termination of follow-up (the
date to which cancer incidence data were available for
women in the corresponding province) or the date of
death, whichever occurred earliest.
Cox proportional hazards models (using age as the time
scale) were used to estimate hazard ratios (HRs) and 95%
confidence intervals (CIs) for ovarian cancer risk in
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association with energy-adjusted quartile levels of GL,
overall GI, and total carbohydrate and total sugar intake;
energy adjustment was performed using the residual
method27. Multivariate models included the variables
listed in the footnote of Table 2. To test for trend, we fitted
the median value of each quartile level as an ordinal
variable in the risk models, and evaluated the statistical
significance of the coefficient using the Wald test28. We
examined the associations overall and within strata
defined by menopausal status. Stratified multivariate
models included the variables listed in a footnote in
Table 3. Tests for interaction were based on likelihood
ratio tests comparing models with and without product
terms representing the variables of interest. Use of the
lifetest procedure in SASw showed that the proportional
hazards assumption was met in this data set. All analyses
were performed using SAS version 9 (SAS Institute). All
statistical tests were two-sided, and P-values ,0.05 were
considered to be statistically significant.
Results
The average duration of follow-up for cohort members
was 16.4 years, corresponding to a total of 801 414 person-
years of follow-up for the cohort. The mean (^standard
deviation (SD)) age at diagnosis for the cases was 59.4
(^7.2) years. For the cohort as a whole, the means (^SD)
of the energy-adjusted overall GI and GL were 79.1
(^23.7) and 147.0 (^35.1) g day21, respectively. There
was an approximately 2-fold variation in mean GL values
between the lowest and highest quartile levels (Table 1).
Compared with those with relatively low GL values,
women with high GL values were less likely to have
consumed alcohol, to have ever smoked, to have had a
relatively early age at menarche and to have ever used oral
contraceptives and hormone replacement therapy, but
they were more likely to be postmenopausal at baseline,
and they consumed more total carbohydrates, sugar and
fibre (Table 1). No appreciable variation was observed in
mean energy intake, age at baseline, body mass index,
participation in vigorous physical activity, parity or age at
first birth by quartile levels of GL. The patterns for overall
GI were similar to those for the GL (data not shown).
Table 2 shows that in age- and energy-adjusted models
there was no association between GL, overall GI, total
carbohydrate or total sugar intake and risk of ovarian
cancer. After multivariate adjustment, the HRs for total
carbohydrate and total sugar remained essentially
unchanged, while there was some suggestion of a weak
positive association with overall GI, although this
association was not statistically significant. In contrast,
after multivariate adjustment, GL was positively associated
with a 72% increase in risk of ovarian cancer (HR for
highest vs. lowest quartile level ¼ 1.72, 95% CI ¼ 1.13–
2.62, Ptrend ¼ 0.01). Mutual adjustment for GI, GL,
carbohydrate and sugar intake in the model did not
materially alter these associations. After additional adjust-
ment for dietary carbohydrate, the association between
overall GI and ovarian cancer risk was not altered
Table 1 Age-adjusted baseline distributions of dietary, lifestyle and hormonal factors by quartiles of energy-adjusted glycaemic
load*
Quartiles of energy-adjusted
glycaemic load (g day21)
,125 125–147 148–169 .169 P-value
Mean glycaemic load (g day21) 103.2 (18.1)† 136.3 (6.4) 157.5 (6.3) 191.0 (20.9) ,0.0001
Mean overall glycaemic index 73.9 (24.5) 79.1 (22.4) 80.6 (22.2) 82.9 (24.6) ,0.0001
Mean total carbohydrates (g day21) 153.0 (52.1) 185.5 (51.7) 209.6 (56.2) 250.2 (80.8) ,0.0001
Mean total sugar (g day21) 61.6 (19.5) 77.3 (19.2) 85.4 (20.4) 99.6 (29.7) ,0.0001
Mean total fibre (g day21) 17.3 (6.2) 20.0 (6.1) 21.4 (6.4) 22.9 (7.7) ,0.0001
Mean energy intake (kcal day21) 2075 (743) 2020 (587) 2058 (577) 2133 (653) ,0.0001
Mean age (years) 48.1 (5.5) 48.5 (5.6) 48.7 (5.7) 48.9 (5.7) ,0.0001
Mean body mass index (kg m22) 25.1 (4.4) 25.0 (5.0) 24.7 (4.3) 24.4 (4.5) ,0.0001
Ever smoker (%) 59.9 50.2 44.4 39.7 ,0.0001
Any alcohol intake (%) 80.3 78.4 73.6 63.4 ,0.0001
Any vigorous physical activity (%) 56.2 59.4 59.8 56.6 0.46
Age at menarche #12 years (%) 42.6 42.1 40.4 37.8 ,0.0001
Ever use of oral contraceptive (%) 63.6 61.5 58.6 53.9 ,0.0001
Postmenopausal at baseline (%) 39.1 42.3 43.6 46.4 ,0.0001
Ever use of hormone replacement therapy (%)‡ 49.7 48.7 47.9 46.5 0.002
Parous (%) 84.6 86.0 85.6 84.3 0.001
Age at first birth§ 23.8 (4.7) 24.2 (4.7) 24.5 (4.7) 24.6 (4.8) ,0.0001
* The main foods contributing to glycaemic load in the cohort include white bread (sliced), rolls, muffins, potatoes (baked, boiled and mashed),
French fries, cakes, cookies, rice, pasta, pizza, cold breakfast cereals, pies and tarts, cola, other soft drinks, citrus fruits and juices and other
fruits, crisp snacks (such as potato chips or popcorn), candy, chocolate, peas, beans and lentils, hot breakfast cereals, dark and wholegrain
breads, corn, root vegetables other than potatoes, jam, jelly and honey, sugar in tea or coffee, ice cream and peanut butter.
† Numbers in parentheses represent the standard deviation.
‡ Among postmenopausal women only.
§ Among parous women only.
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substantially (HR highest vs. lowest quartile ¼ 1.25, 95%
CI ¼ 0.64–2.45), but the positive association between GL
and ovarian cancer risk was somewhat stronger (HR
highest vs. lowest quartile ¼ 2.15, 95% CI ¼ 1.29–3.60;
data not shown).
While GL was positively associated with risk of ovarian
cancer in both premenopausal and postmenopausal
women (Table 3), the risk for the highest relative to the
lowest quartile level appeared to be slightly greater among
postmenopausal (HR ¼ 1.89, 95% CI ¼ 0.98–3.35,
Ptrend ¼ 0.03) than among premenopausal women
(HR ¼ 1.65, 95% CI ¼ 0.95–2.88, Ptrend ¼ 0.07). However,
on formal testing, the interaction between GL and
menopausal status was not statistically significant
(x 2(3) ¼ 2.18, P ¼ 0.54). Similarly, although the HR for
ovarian cancer risk associated with a relatively high overall
GI was above unity among postmenopausal (HR ¼ 1.88,
95% CI ¼ 0.71–5.00, Ptrend ¼ 0.44) but not premeno-
pausal women (HR ¼ 0.92, 95% CI ¼ 0.37–2.29,
Ptrend ¼ 0.95), the interaction between GI andmenopausal
status was not statistically significant (x 2(3) ¼ 4.37,
P ¼ 0.22). There was no association between total
carbohydrate intake and ovarian cancer risk among
pre- or postmenopausal women (Ptrend ¼ 0.70 and
Ptrend ¼ 0.86, respectively), whereas for total sugar
consumption there was no association with risk among
premenopausal women but some suggestion of a
positive association among postmenopausal women
(Ptrend ¼ 0.84 and Ptrend ¼ 0.08, respectively).
No heterogeneity of results was found upon stratifica-
tion by smoking history (ever vs. never), age at menarche,
use of hormone replacement therapy or alcohol con-
sumption. There was some evidence of heterogeneity by
parity (parous vs. non-parous) for GI (x 2(3) ¼ 10.62,
P ¼ 0.01), but not GL (x 2(3) ¼ 2.27, P ¼ 0.52), carbo-
hydrate intake (x 2(3) ¼ 6.07, P ¼ 0.11) or sugar con-
sumption (x 2(3) ¼ 2.68, P ¼ 0.44).
The results for each of the analyses presented above
were similar after exclusion of case subjects diagnosed
within 1 year of recruitment (n ¼ 10).
Discussion
In the prospective study reported here, we found a strong
positive association between GL and ovarian cancer risk
over a 16-year follow-up period. In contrast, there was no
association between overall GI, total carbohydrate or total
sugar intake, and risk over a 16-year follow-up period in
the total study population. Although the association with
GL was slightly stronger in women who were postmeno-
pausal at baseline than in those who were premenopausal,
there was no statistical evidence of effect modification by
baseline menopausal status. Indeed, given that 88% of
ovarian cancer cases in our study population were
diagnosed at or above 51 years of age, the average age
at menopause in North America31, it is evident that our
results are largely representative of ovarian cancers
diagnosed postmenopausally. Our finding of an associ-
ation with GL but not GI may reflect the fact that the
proportion of high-GI foods in the diet may not be as good
an indicator of physiological response as GL, which also
takes into account the quantity of intake of rapidly
absorbed carbohydrates26.
Only one previous study has examined the association
between GI, GL and ovarian cancer risk. In that
investigation, a case–control study in Italy, Augustin
et al.17 analysed data on 1031 incident cases and 2411
controls, and found a statistically significant increase in
ovarian cancer risk among women in the highest vs. the
lowest quartile levels for GL and GI. Similar to our
findings, upon stratification by menopausal status, GI and
GL were associated more strongly with ovarian cancer risk
among postmenopausal women17.
Three case–control studies17,29,30 and one prospective
study31 have examined the association between total
carbohydrate intake and ovarian cancer risk. Of these, two
studies found a statistically significant positive association
between total carbohydrate intake and risk17,30 and one
Table 2 Adjusted* hazard ratios and 95% confidence intervals for
the association between overall glycaemic index, glycaemic load,
total carbohydrate intake, total sugar intake and risk of ovarian
cancer
Hazard ratio






Glycaemic load (g day21)
, 125 53/201 225 1.00 (referent) 1.00 (referent)
125–147 68/200 534 1.30 (0.91–1.88) 1.45 (0.96–2.19)
148–169 75/200 269 1.44 (1.00–2.06) 1.93 (1.29–2.88)
. 169 68/199 385 1.33 (0.93–1.92) 1.72 (1.13–2.62)
P for trend 0.10 0.004
Overall glycaemic index
, 63 70/200 001 1.00 (referent) 1.00 (referent)
64–76 65/200 653 0.95 (0.67–1.33) 1.26 (0.81–1.98)
77–92 71/200 118 1.03 (0.74–1.44) 1.29 (0.75–2.21)
. 92 58/200 641 0.82 (0.58–1.17) 1.27 (0.65–2.47)
P for trend 0.37 0.66
Total carbohydrate (g day21)
, 152 59/201 124 1.00 (referent) 1.00 (referent)
152–191 78/200 523 1.31 (0.93–1.84) 1.33 (0.89–1.98)
192–236 52/200 544 0.85 (0.58–1.24) 0.96 (0.60–1.54)
. 236 75/199 223 1.30 (0.92–1.84) 1.33 (0.75–2.35)
P for trend 0.37 0.42
Total sugar (g day21)
, 64 60/200 227 1.00 (referent) 1.00 (referent)
64–79 63/200 662 1.06 (0.74–1.51) 1.13 (0.76–1.69)
80–95 80/200 385 1.31 (0.93–1.84) 1.68 (1.14–2.47)
. 95 61/200,139 0.98 (0.87–1.41) 1.17 (0.76–1.79)
P for trend 0.85 0.21
* Multivariable models included age (time to event variable), body mass
index in kg m22 (,25, 25–29, $30), alcohol (any vs. none), use of hor-
mone replacement therapy (ever vs. never), use of oral contraceptives
(ever vs. never), parity (parous vs. nulliparous), age at menarche (#12 vs.
.12 years of age), menopausal status at baseline, total energy intake (as
a continuous variable), participation in vigorous physical activity (any vs.
none), energy-adjusted total fibre intake (quartiles), study centre and treat-
ment allocation (intervention vs. control).
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found no association29. In addition, Kushi et al.31 analysed
data from the Iowa Women’s Health Study (139 incident
cases) and, in contrast to our findings, observed an 83%
increase in ovarian cancer risk associated with the highest
vs. the lowest quartile level of total carbohydrate intake
(relative risk ¼ 1.83, 95% CI ¼ 1.07–3.13).
To date, only two case–control studies have examined
the association between total dietary sugar intake and
ovarian cancer risk, of which one32 found no association,
while the other33 found a positive association. We are
unaware of anyprevious cohort studies that have examined
total sugar intake in association with ovarian cancer risk.
Our data are limited by the possibility of error with
respect to the measurement of diet and the calculation of
GL. Error in the measurement of daily intake of
carbohydrates and sugars may have resulted from
inaccurate recall34. Furthermore, measurement error
might have occurred due to the fact that the GI values of
some foods are currently based on only one or two, often
small, studies15. In addition, no biological specimens were
collected and we were therefore unable to test for the
presence of relevant biomarkers such as IGF. Finally,
although we adjusted our estimates for a wide range of
potentially confounding variables, uncontrolled con-
founding by dietary and other factors cannot be excluded.
In conclusion, the results of our study suggest that
dietary GL is associated with an increase in the risk of
ovarian cancer. Our findings add to the growing body of
knowledge concerning the potentially deleterious effects
of high-GL diets35–37.
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Table 3 Adjusted* hazard ratios and 95% confidence intervals for the association between overall glycaemic
index, glycaemic load, total carbohydrate intake, total sugar intake and risk of ovarian cancer, stratified by
menopausal status
Hazard ratio (95% confidence interval)
Premenopausal Postmenopausal P for interaction
No. of cases/person-years 124/398 661 109/292 524
Glycaemic load (g day21)†
, 125 1.00 (referent) 1.00 (referent)
125–147 1.38 (0.81–2.35) 1.58 (0.81–3.06)
148–169 1.54 (0.90–2.64) 2.59 (1.39–4.84)
. 169 1.65 (0.95–2.88) 1.89 (0.98–3.65)
P for trend 0.07 0.03 0.54
Overall glycaemic index†
, 63 1.00 (referent) 1.00 (referent)
64–76 1.00 (0.53–1.83) 1.67 (0.86–3.25)
77–92 1.30 (0.64–2.66) 1.25 (0.55–2.87)
. 92 0.92 (0.37–2.29) 1.88 (0.71–5.00)
P for trend 0.95 0.44 0.22
Total carbohydrate (g day21)
, 152 1.00 (referent) 1.00 (referent)
152–191 1.29 (0.75–2.20) 1.35 (0.74–2.47)
92–236 0.93 (0.48–1.77) 0.98 (0.49–1.99)
. 236 1.40 (0.64–3.06) 1.26 (0.54–2.93)
P for trend 0.70 0.86 1.00
Total sugar (g day21)
,64 1.00 (referent) 1.00 (referent)
64–79 0.89 (0.53–1.49) 1.67 (0.87–3.21)
80–95 1.38 (0.84–2.26) 2.35 (1.24–4.44)
. 95 0.87 (0.49–1.56) 1.79 (0.91–3.50)
P for trend 0.84 0.08 0.31
* Multivariable models included age (time to event variable), body mass index in kg m22 (,25, 25–29, $30), alcohol (any
vs. none), use of hormone replacement therapy (ever vs. never), use of oral contraceptives (ever vs. never), parity (parous
vs. nulliparous), age at menarche (#12 vs. .12 years of age), menopausal status at baseline, total energy intake (as a
continuous variable), participation in vigorous physical activity (any vs. none), energy-adjusted total fibre intake (quartiles),
study centre and treatment allocation (intervention vs. control).
† The total number of cases does not equal 264 because women classified as perimenopausal were not included in these
analyses.
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